Top 20 own 69%, Top 100 must be close to 87%, which means the loose shares coming onto market providing liquidity will be minimal .
No doubt some of the BP clients will have a robotic mentality just to lock in a profit on day 1 , but i have a feeling the market in general will like the look of the upside from here , especially given the success and early days market caps already seen in other CAR T junior BioTechs. And not to mention, first patients were already dosed last year, so seeing a positive update in the near future is more than likely.
CHM Price at posting:
11.5¢ Sentiment: Buy Disclosure: Not Held
(20min delay)